TGFB1 and Hepatic fibrosis: Treatment with Diwu Yanggan (DWYG) significantly decreased the hepatic hydroxyproline content and degree of CCl4-induced liver fibrosis in rats [94] and stimulated MET in the fibrotic liver through inhibition of the TGF-β1/BMP-7 signaling pathway [94].